Contributor Disclosures for Anterior Segment and Fundus Photography

Role Name Disclosure Details Author  Michael F Chiang, MD, MA, Assistant Professor, Departments of Ophthalmology and Biomedical Informatics, Columbia University College of Physicians and Surgeons; Consulting Staff, Columbia University Medical Center Nothing to disclose Details Coauthor  Michael R Turano, Jr, CRA, Supervisor, Digital & Media Services, Department of Ophthalmology, Columbia University Medical Center Nothing to disclose Details Coauthor  Lawrence M Merin, RBP, FIMI, FOPS, FBCA, Assistant Professor of Ophthalmology, Director of Ophthalmic Imaging Center, Department of Ophthalmology and Visual Sciences, Vanderbilt University Nothing to disclose Details Medical Editor  Gerhard W Cibis, MD, Director of Pediatric Ophthalmology Service, Clinical Professor, Clinical Professor, Department of Ophthalmology, Department of Ophthalmology, University of Kansas; Director, Children's Mercy Hospital, University of Missouri at Kansas City Nothing to disclose Details Pharmacy Editor  Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to disclose Details Managing Editor  Steve Charles, MD, Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine Alcon Laboratories Details CME Editor  Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri Nothing to disclose Details Chief Editor  Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences Nothing to disclose Details eMedicine Code of Ethics 1. eMedicine.com, Inc, henceforth referred to as eMedicine, is dedicated to providing up-to-date, peer-reviewed medical information. This information may be accessed in various ways; however, the primary delivery portal is the Internet. The free availability of our medical journals online reflects the commitment of eMedicine to disseminate knowledge to the widest possible audience, including individuals, groups, or populations that may not otherwise have access to such medical information. 2. eMedicine is committed to publishing medical journals of high quality. To achieve this end, all eMedicine topics are reviewed and edited by 4 physicians and a doctor of pharmacy. eMedicine strives to ensure that any claims relating to the benefits of a specific treatment, commercial product, or service are supported by appropriate, balanced evidence. Therefore, each article contains references to sources used when writing the topic and the date when clinical information was last modified. 3. eMedicine respects and values the sanctity of the physician-patient relationship. Information provided by eMedicine is designed to support, not replace, the relationships that exist among patients and their physicians and other health care providers. Accordingly, eMedicine's authors and editors do not provide patient consultation through email. 4. eMedicine's owners, staff, authors, editors, and advertisers maintain the confidentiality of the identity of individual patients whose cases may be presented and that of visitors to the eMedicine Web site. 5. eMedicine is a privately held organization. Advertising by commercial and noncommercial organizations that provide funding, services, or materials for eMedicine activities does not influence medical content. eMedicine's advertising and promotional material is subject to review by the Ethics Committee and is presented to viewers in a manner and context that facilitates differentiation between the advertising and promotional material and the original textual information. 6. eMedicine does not endorse any medical institution, biomedical technology, or pharmaceutical product. Furthermore, eMedicine requires authors to report any conflict of interest (eg, financial interest in any medical companies, pharmaceutical company funding of topic-related research) and posts such disclosures in each article. For further information, contact Lynn Barkley Burnett, EdD, MS, Chair, eMedicine Ethics Committee.

CONTRIBUTOR DISCLOSURE FORM

Contributor Name: Michael F Chiang  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication

Contributor Disclosure

Contributor:	Contributor Disclosure:
Michael R Turano, Jr, Coauthor	The contributor discloses no conflict of interest.

Contributor Disclosure

Contributor:	Contributor Disclosure:
Lawrence M Merin, Coauthor	The contributor discloses no conflict of interest.

Contributor Disclosure

Contributor:	Contributor Disclosure:
Gerhard W Cibis, Medical Editor	The contributor discloses no conflict of interest.

CONTRIBUTOR DISCLOSURE FORM

Contributor Name: Francisco Talavera  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication

CONTRIBUTOR DISCLOSURE FORM

Contributor Name: Steve Charles  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Alcon Laboratories Consulting fee Consulting   Off label or investigational use of medication

CONTRIBUTOR DISCLOSURE FORM

Contributor Name: Lance L Brown  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication

CONTRIBUTOR DISCLOSURE FORM

Contributor Name: Hampton Roy, Sr  DECLARATION STATEMENT I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity. COMMERCIAL INTEREST (Name of Organization) Self Spouse/ Partner NATURE OF RELEVANT FINANCIAL RELATIONSHIP What was received?* For what role?** Off label or investigational use of medication